GENEASSESS
GeneAssess, Inc. is a New Jersey-based biotechnology company that is working to validate FRY, a cancer molecular signature gene discovered by GeneAssess scientists that could provide a more accurate diagnostic biomarker for cancer staging. The FRY gene appears to be found in the breast cancer model but also shows potential for other cancers. In research performed to date, mutations in the gene increase rat susceptibility to mammary cancer and FRY reduced the growth of highly aggressive hu... man breast cancer cells in animal models. GeneAssess plans to validate FRY as a predictive biomarker for breast and other cancers, to detect genetic mutations in at-risk populations and to explore target validation for FRY. The company has an exclusive license to the intellectual property developed by Dr. Zarbl.
GENEASSESS
Industry:
Biotechnology Genetics
Founded:
2012-01-01
Address:
New Brunswick, New Jersey, United States
Country:
United States
Website Url:
http://www.geneassess.biz
Total Employee:
1+
Status:
Active
Contact:
(908)-731-6610
Email Addresses:
[email protected]
Total Funding:
500 K USD
Technology used in webpage:
LetsEncrypt Domain Not Resolving Mobile Non Scaleable Content Nginx
Similar Organizations
Applied StemCell
Applied StemCell is a biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics.
ArcherDX
ArcherDX is a biotechnology firm specializing in cancer research.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Employees Featured
Founder
Investors List
Foundation Venture Capital Group
Foundation Venture Capital Group investment in Venture Round - GeneAssess
